STAT3 is a key oncogenic factor in the JAK-STAT signaling pathway, and abnormal activation of STAT3 has been widely reported in various cancers, including lung cancer and hepatocellular carcinoma [37,38,39]. This evidence concerns the gene SOAT1 and hepatocellular carcinoma.